<DOC>
	<DOCNO>NCT00483392</DOCNO>
	<brief_summary>The purpose study evaluate compare effect treatment rosiglitazone metformin insulin resistance patient infected Human Immunodeficiency Virus stable Highly Active Antiretroviral Therapy include Protease Inhibitor period 48 week .</brief_summary>
	<brief_title>Treatment Hyperglycaemia Insulin Resistance HIV Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>document HIV infection stable Protease Inhibitor contain HAART regimen least 12 month impair glucose tolerance elevate insulin level ( 20 mIU/l ) patient already take oral hypoglycaemic treatment insulin heart failure NYHA IIV liver disease kidney disease elevate AST ALT 2 time upper normal range elevate creatinine ( 150 mmol/l )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>insulin</keyword>
	<keyword>rosiglitazone</keyword>
	<keyword>metformin</keyword>
	<keyword>hiv</keyword>
	<keyword>protease inhibitor</keyword>
</DOC>